

Johnson & Johnson posted upbeat Q3 results; analysts stayed bullish, though RBC cut its target and noted mixed product and MedTech trends.
You can purchase shares of Johnson & Johnson (NYSE:JNJ) through any online brokerage.
Other companies in Johnson & Johnson’s space includes: Eli Lilly and Co (NYSE:LLY), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS), AstraZeneca PLC (NYSE:AZN) and Novo Nordisk AS (NYSE:NVO).
Johnson & Johnson has a consensus price target of $265.13.
The stock price for Johnson & Johnson (NYSE: JNJ) is $267.33 last updated November 6, 2026 at 7:22 AM EST.
There are no upcoming dividends for Johnson & Johnson.
Johnson & Johnson does not have any upcoming earnings scheduled.
There is no upcoming split for Johnson & Johnson.
Johnson & Johnson is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After...